Thane Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 01-01-2025
- Paid Up Capital ₹ 0.10 M
as on 01-01-2025
- Company Age 19 Year, 17 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.67 Cr
as on 01-01-2025
- Satisfied Charges ₹ 1.60 Cr
as on 01-01-2025
- Revenue 50.52%
(FY 2022)
- Profit 796.93%
(FY 2022)
- Ebitda 262.40%
(FY 2022)
- Net Worth 6.56%
(FY 2022)
- Total Assets 7.89%
(FY 2022)
About Thane Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.67 Cr. The company has closed loans amounting to ₹1.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajas Chaubal, Nitin Chaubal, and Jyoti Chaubal serve as directors at the Company.
- CIN/LLPIN
U73100MH2005PTC158732
- Company No.
158732
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2005
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationThane, Maharashtra
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Thane Diagnostics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajas Chaubal  | Director | 30-Dec-2005 | Current |
| Nitin Chaubal | Director | 30-Dec-2005 | Current |
| Jyoti Chaubal | Director | 30-Dec-2005 | Current |
Financial Performance of Thane Diagnostics.
Thane Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 50.52% increase. The company also saw a substantial improvement in profitability, with a 796.93% increase in profit. The company's net worth moved up by a moderate rise of 6.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thane Diagnostics?
In 2021, Thane Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Apr 2023 | ₹0.60 M | Open |
Hdfc Bank Limited Creation Date: 24 Aug 2022 | ₹1.35 M | Open |
Tjsb Sahakari Bank Limited Creation Date: 30 Dec 2019 | ₹5.85 M | Open |
How Many Employees Work at Thane Diagnostics?
Thane Diagnostics has a workforce of 25 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thane Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thane Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
